Differentiation of strains of Mycoplasma fermentans from various sources by pyrolysis mass spectrometry

Journal of Medical Microbiology

Volumn 46, Issue 4, 1997, Pages 348-353

  Hannan, P C T ^a   Kearns, A M ^b   Sisson, P R ^b   Freeman, R ^b  

^a Mycoplasma Experience Ltd   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIUM IDENTIFICATION; CANADA; CELL CULTURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; EUROPE; HUMAN; MASS SPECTROMETRY; MYCOPLASMA HOMINIS; PRIORITY JOURNAL; PYROLYSIS;

EID: 0030897148     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-4-348     Document Type: Article

References (23)

1. Ruiter M, Wentholt HMM. The occurrence of a pleuropneumonia-like organism in fuso-spirillary infections of the human genital mucosa. J Invest Dermatol 1952; 18: 313 325.
2. Cassell GH, Yanez A, Duffy LB et al. Detection of Mycoplasma fermentans in the respiratory tract of children with pneumonia. IOM Letters Vol 3, 10th International Congress of the International Organisation for Mycoplasmology (IOM), Bordeaux, France, July 19 26, 1994: 45.
3. Lo S-C, Wear DJ, Green SL, Jones PG, Legier JF. Adult repiratory distress syndrome with or without systemic disease associated with infections due to Mycoplasma fermentans. Clin Infect Dis 1993; 17 Suppl 1: S259 S263.
4. Williams MH. Recovery of mycoplasmas from rheumatoid synovial fluid. In: Third Pfizer International Symposium on 'Rheumatic Diseases'. Edinburgh, Edinburgh University Press. 1968: 171 181.
5. Murphy WH, Bullis C, Ertel IJ, Zarafonetis CJD. Mycoplasma studies on human leukemia. Ann NY Acad Sci 1967; 143: 544 556.
6. Lo S-C, Shih JW-K, Yang N-Y, Ou C-Y, Wang RY-H. A novel virus-like infectious agent in patients with AIDS. Am J Trop Med Hyg 1989; 40: 213 226.
7. Montagnier L, Berneman D, Guétard D et al. Inhibition de l'infectiosité de souches prototypes du VIH par des anticorps dirigés contre une séquence peptidique de mycoplasme. [Infectivity inhibition of HIV prototype strains by antibodies directed against a peptide sequence of mycoplasma.] C R Acad Sci Paris [III] 1990; 311: 425 430.
8. Dawson MS, Hayes MM, Wang RY-H, Armstrong D, Kundsin RB, Lo S-C. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type-1-infected patients. Arch Pathol Lab Med 1993; 117: 511 514
9. Lo S-C, Dawson MS, Newton PB et al. Association of the virus-like infectious agent originally reported in patients with AIDS with acute fatal disease in previously healthy non-AIDS patients. Am J Trop Med Hyg 1989; 41: 364 376.
10. Wang RY-H, Hu WS, Dawson MS, Shih JW-K, Lo S-C. Selective detection of Mycoplasma fermentans by polymerase chain reaction and by using a nucleotide sequence within the insertion sequence-like element. J Clin Microbiol 1992; 30: 245 248.
11. Hu WS, Wang RY-H, Shih JW-K, Lo S-C. Identification of a putative infC-rpml-rplT operon flanked by long inverted repeats in Mycoplasma fermentans (incognitus strain). Gene 1993; 127: 79 85.
12. Sasaki T, Sasaki Y, Kita M, Suzuki K, Watanabe H, Honda M. Evidence that Lo's Mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains. J Clin Microbiol 1992; 30: 2435 2440.
13. Saillard C, Carle P, Bové JM et al. Genetic and serologic relatedness between Mycoplasma fermentans strains and a mycoplasma recently identified in tissues of AIDS and non-AIDS patients. Res Virol 1990; 141: 385-395.
14. Sisson PR, Lightfoot NF, Freeman R. Pyrolysis mass spectrometry of micro-organisms. PHLS Microbiol Digest 1992; 9: 65 68.
15. Sisson PR, Kramer JM, Brett MM, Freeman R, Gilbert RJ, Lighlfoot NF. Application of pyrolysis mass spectrometry to the investigation of outbreaks of food poisoning and non-gastrointestinal infection associated with Bacillus species and Clostridium perfringens. Int J Food Microbiol 1992; 17: 57 66.
16. Magee J. Whole-organism fingerprinting. In: Goodfellow M, O'Donnell AG (eds) Handbook of new bacterial systematics. London, Academic Press. 1993: 383 427.
17. Kearns AM, Sisson PR, Freeman R, Lightfoot NF. Characterisation of Mycoplasma species by pyrolysis mass spectrometry. IOM Letters Vol 3. 10th International Congress of the International Organisation for Mycoplasmology (IOM), Bordeaux, France. July 19 26, 1994: 594.
18. Kearns AM, Hannan PCT, Sisson PR, Freeman R. Mycoplasma fermentans isolates characterised by pyrolysis mass spectrometry. IOM Letters Vol 4, 11th International Congress of the International Organisation for Mycoplasmology (IOM). Orlando, Florida, USA. July 14 19, 1996: 170.
19. Hunnan PCT. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro. J Med Microbiol 1995; 42: 421 428.
20. Hannan PCT. In vitro susceptibilities of AIDS-associated and human urogenital tract mycoplasmas to ten classes of antimicrobial agent. IOM Letters Vol 4. 11th International Congress of the International Organisation for Mycoplasmology (IOM), Orlando, Florida, USA, July 14 19, 1996: 396 397.
21. Poulin SA, Perkins RE, Kundsin RB. Antibiotic susceptibilities of AIDS-associated mycoplasmas. J Clin Microbiol 1994; 32: 1101-1103.
22. Freundt EA. Modified Hayflick medium: in culture media for classic mycoplasmas. In: Razin S, Tully JG (eds) Methods in mycoplasmology, Vol 1. New York, Academic Press. 1983: 130.
23. Clyde WA. Mycoplasma species identification based upon growth inhibition by specific antisera. J Immunol 1964; 92: 958-965.